The impact of the first three months of the COVID-19 pandemic on the Australian trans community.

COVID-19 Coronavirus depression suicidality transgender

Journal

International journal of transgender health
ISSN: 2689-5277
Titre abrégé: Int J Transgend Health
Pays: United States
ID NLM: 101765532

Informations de publication

Date de publication:
2023
Historique:
medline: 11 3 2021
pubmed: 11 3 2021
entrez: 31 7 2023
Statut: epublish

Résumé

Trans and gender diverse individuals (people who identify with a gender different to what was presumed for them at birth) are one of the most medically and socially marginalized groups in our community. The COVID-19 pandemic may compound preexisting depression and thoughts of self-harm or suicide. We aimed to explore the impact of the COVID-19 pandemic on the Australian trans community. An online cross-sectional survey was conducted between 1st May 2020 and 30th June 2020, amidst strict Australia-wide social restrictions. Australian trans people aged ≥16 years were eligible to participate. Survey questions explored the impact of the COVID-19 pandemic on living situation, employment, financial situation, and healthcare. Logistic regression to assess negative impacts due to COVID-19 on depression and thoughts of self-harm or suicide (measured by Patient Health Questionnaire-9 (PHQ-9) are presented as odds ratios (95% confidence interval)). Of 1019 participants, 49.6% reported experiencing financial strain, 22% had reduced working hours, and 22.4% were unemployed (three times the national rate). Concerningly, 61.1% experienced clinically significant symptoms of depression (Patient Health Questionnaire-9 score ≥10), considerably higher than pre-COVID rates for the trans community and over twice the national rate. Moreover, 49% reported thoughts of self-harm or suicide (over three times the national rate) which was more likely if a person experienced cancelation or postponement of gender-affirming surgery (OR 1.56 (1.04, 2.35)), financial strain (OR 1.80 (1.36, 2.38)), or felt unsafe or afraid in their household (OR 1.96 (1.23, 3.08)). Given rates of clinically significant depression and thoughts of self-harm or suicide are far higher in trans people than the general population, specific strategies to improve mental health in the trans community during the COVID-19 pandemic must be made a priority for policymakers, researchers, and health service providers to prevent suicide. Supplemental data for this article is available online at https://doi.org/10.1080/26895269.2021.1890659.

Sections du résumé

Background UNASSIGNED
Trans and gender diverse individuals (people who identify with a gender different to what was presumed for them at birth) are one of the most medically and socially marginalized groups in our community. The COVID-19 pandemic may compound preexisting depression and thoughts of self-harm or suicide.
Aim UNASSIGNED
We aimed to explore the impact of the COVID-19 pandemic on the Australian trans community.
Methods UNASSIGNED
An online cross-sectional survey was conducted between 1st May 2020 and 30th June 2020, amidst strict Australia-wide social restrictions. Australian trans people aged ≥16 years were eligible to participate. Survey questions explored the impact of the COVID-19 pandemic on living situation, employment, financial situation, and healthcare. Logistic regression to assess negative impacts due to COVID-19 on depression and thoughts of self-harm or suicide (measured by Patient Health Questionnaire-9 (PHQ-9) are presented as odds ratios (95% confidence interval)).
Results UNASSIGNED
Of 1019 participants, 49.6% reported experiencing financial strain, 22% had reduced working hours, and 22.4% were unemployed (three times the national rate). Concerningly, 61.1% experienced clinically significant symptoms of depression (Patient Health Questionnaire-9 score ≥10), considerably higher than pre-COVID rates for the trans community and over twice the national rate. Moreover, 49% reported thoughts of self-harm or suicide (over three times the national rate) which was more likely if a person experienced cancelation or postponement of gender-affirming surgery (OR 1.56 (1.04, 2.35)), financial strain (OR 1.80 (1.36, 2.38)), or felt unsafe or afraid in their household (OR 1.96 (1.23, 3.08)).
Discussion UNASSIGNED
Given rates of clinically significant depression and thoughts of self-harm or suicide are far higher in trans people than the general population, specific strategies to improve mental health in the trans community during the COVID-19 pandemic must be made a priority for policymakers, researchers, and health service providers to prevent suicide.
Supplemental data for this article is available online at https://doi.org/10.1080/26895269.2021.1890659.

Identifiants

pubmed: 37519916
doi: 10.1080/26895269.2021.1890659
pii: 1890659
pmc: PMC10373614
doi:

Types de publication

Journal Article

Langues

eng

Pagination

281-291

Informations de copyright

© 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.

Déclaration de conflit d'intérêts

The authors have nothing to disclose.

Références

Lancet Psychiatry. 2015 Mar;2(3):239-45
pubmed: 26359902
Am J Public Health. 2013 May;103(5):943-51
pubmed: 23488522
Transgend Health. 2017 Apr 01;2(1):60-75
pubmed: 28861548
Psychol Med. 2018 Oct;48(14):2329-2336
pubmed: 29331161
Lancet Psychiatry. 2020 Jun;7(6):468-471
pubmed: 32330430
Am J Public Health. 2017 Feb;107(2):213-215
pubmed: 27997239
Health Econ. 2012 Mar;21(3):338-50
pubmed: 21322087
Arch Sex Behav. 2010 Dec;39(6):1415-28
pubmed: 19937374
BMC Public Health. 2015 Jun 02;15:525
pubmed: 26032733
Psychol Med. 2020 Apr;50(5):808-817
pubmed: 31280740
J Clin Nurs. 2020 Jul;29(13-14):2047-2049
pubmed: 32281158
Med Care. 2016 Nov;54(11):1010-1016
pubmed: 27314263
Ann Fam Med. 2010 Jul-Aug;8(4):348-53
pubmed: 20644190
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Arch Sex Behav. 2013 Jul;42(5):739-52
pubmed: 23613139
Transgend Health. 2016 Jan;1(1):21-31
pubmed: 27595141
BMJ. 2019 Apr 9;365:l1476
pubmed: 30967483
BMC Public Health. 2014 Mar 06;14:230
pubmed: 24597614
J Epidemiol Community Health. 2003 Aug;57(8):594-600
pubmed: 12883065
LGBT Health. 2021 Jan;8(1):42-49
pubmed: 33297824
Lancet Diabetes Endocrinol. 2020 Jul;8(7):564-565
pubmed: 32445629
PLoS One. 2018 Oct 5;13(10):e0204606
pubmed: 30289896
Int J Environ Res Public Health. 2019 Dec 13;16(24):
pubmed: 31847083
LGBT Health. 2020 Jan;7(1):1-14
pubmed: 31794289
Acta Psychiatr Scand. 2020 Jun;141(6):486-491
pubmed: 32072611
Med J Aust. 2020 Nov;213(10):458-464
pubmed: 33107063
Aust N Z J Psychiatry. 2021 Apr;55(4):391-399
pubmed: 33198483
Arch Sex Behav. 2020 Oct;49(7):2673-2681
pubmed: 32285311
Psychiatry Res. 2015 Feb 28;225(3):291-8
pubmed: 25578983
Lancet Psychiatry. 2020 Oct;7(10):883-892
pubmed: 32707037
Gen Hosp Psychiatry. 2019 Jan - Feb;56:13-18
pubmed: 30508772

Auteurs

Sav Zwickl (S)

Trans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.

Lachlan M Angus (LM)

Trans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.
Department of Endocrinology, Austin Health, Gender Clinic, Heidelberg, Victoria, Australia.

Alex Wong Fang Qi (AWF)

Trans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.

Ariel Ginger (A)

Trans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.

Kalen Eshin (K)

La Trobe University, Bundoora, Victoria, Australia.

Teddy Cook (T)

ACON Health, Surry Hills, New South Wales, Australia.

Shalem Y Leemaqz (SY)

Trans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.
Flinders University, Adelaide, South Australia, Australia.

Eden Dowers (E)

Swinburne University of Technology, Hawthorn, Victoria, Australia.

Jeffrey D Zajac (JD)

Trans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.
Department of Endocrinology, Austin Health, Gender Clinic, Heidelberg, Victoria, Australia.

Ada S Cheung (AS)

Trans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.
Department of Endocrinology, Austin Health, Gender Clinic, Heidelberg, Victoria, Australia.

Classifications MeSH